Bi-allelic inheritance of mutations in FANCJ, similar to PALB2 and BRCA2, contributes to Fanconi anemia, a rare cancer-prone disease characterized by extreme cellular sensitivity to agents that ...

Its clinical program is an LVV-based gene therapy for the treatment of Fanconi Anemia (FA), a difficult to treat genetic disease that leads to bone marrow failure and potentially cancer.